{"filing":{"accession_number":"0001628280-26-063084","cik":"0001372299","ticker":"OCGN","company_name":"Ocugen, Inc.","form":"8-K","filing_date":"2026-09-22","report_date":"2026-09-21","primary_document":"ocgn-20260921.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1372299/000162828026063084/ocgn-20260921.htm"},"events":[{"id":34413,"run_id":31660,"accession_number":"0001628280-26-063084","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This Item 5.07 disclosure reports the results of a Special Meeting of Stockholders held on September 21, 2026, where stockholders voted on Proposal 2 (adjournment to solicit additional proxies for a capital authorization increase). The filing tabulates votes for, against, and abstentions (124,584,658 for, 33,639,820 against, 1,989,953 abstentions), which is the core content of shareholder vote results. The material proposal (Proposal 1 to increase authorized common shares by 250 million) was adjourned to October 5, 2026, making this a partial vote result disclosure typical of Item 5.07.","company_name":"Ocugen, Inc.","ticker":"OCGN","filing_date":"2026-09-22","form":"8-K","submitted_at":null,"items":[{"id":38125,"accession_number":"0001628280-26-063084","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This Item 5.07 disclosure reports the results of a Special Meeting of Stockholders held on September 21, 2026, where stockholders voted on Proposal 2 (adjournment to solicit additional proxies for a capital authorization increase). The filing tabulates votes for, against, and abstentions (124,584,658 for, 33,639,820 against, 1,989,953 abstentions), which is the core content of shareholder vote results. The material proposal (Proposal 1 to increase authorized common shares by 250 million) was adjourned to October 5, 2026, making this a partial vote result disclosure typical of Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T10:00:46.510960+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38125,"accession_number":"0001628280-26-063084","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This Item 5.07 disclosure reports the results of a Special Meeting of Stockholders held on September 21, 2026, where stockholders voted on Proposal 2 (adjournment to solicit additional proxies for a capital authorization increase). The filing tabulates votes for, against, and abstentions (124,584,658 for, 33,639,820 against, 1,989,953 abstentions), which is the core content of shareholder vote results. The material proposal (Proposal 1 to increase authorized common shares by 250 million) was adjourned to October 5, 2026, making this a partial vote result disclosure typical of Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T10:00:46.510960+00:00","company_name":"Ocugen, Inc.","ticker":"OCGN","filing_date":"2026-09-22"}]}